We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIRM icon
176
Mirum Pharmaceuticals
MIRM
$5.74B
$1.02M 0.02%
22,560
-2,499
-10% -$118K
KR icon
177
Kroger
KR
$35.1B
$1.02M 0.02%
+15,000
New +$951K
PRAX icon
178
Praxis Precision Medicines
PRAX
$10.3B
$1.01M 0.02%
26,793
+290
+1% +$18.1K
RCUS icon
179
Arcus Biosciences
RCUS
$3.61B
$1.01M 0.02%
128,688
+52,042
+68% +$603K
RLAY icon
180
Relay Therapeutics
RLAY
$4.3B
$1M 0.02%
382,900
+52,201
+16% +$205K
KALA icon
181
KALA BIO
KALA
$14.2M
$979K 0.02%
3,418
-161
-4% -$60.9K
COST icon
182
Costco
COST
$421B
$946K 0.02%
+1,000
New +$975K
TERN
183
DELISTED
Terns Pharmaceuticals
TERN
$928K 0.02%
336,144
+195,844
+140% +$800K
RIG icon
184
PUT
Transocean
RIG
$5.71B
$927K 0.02%
803,400
– –
ANNX icon
185
Annexon
ANNX
$918M
$901K 0.02%
466,819
+147,935
+46% +$492K
DAWN
186
DELISTED
Day One Biopharmaceuticals
DAWN
$898K 0.02%
113,250
+63,230
+126% +$681K
SRRK icon
187
Scholar Rock
SRRK
$6.41B
$888K 0.02%
+27,617
New +$1.06M
AURA icon
188
Aura Biosciences
AURA
$799M
$885K 0.02%
151,108
+14,592
+11% +$110K
IQV icon
189
IQVIA
IQV
$38.3B
$882K 0.02%
+5,000
New +$970K
BBIO icon
190
BridgeBio Pharma
BBIO
$16.2B
$881K 0.02%
25,492
-35,626
-58% -$1.2M
EWTX icon
191
Edgewise Therapeutics
EWTX
$4.78B
$880K 0.02%
+40,014
New +$1.05M
ANAB icon
192
AnaptysBio
ANAB
$1.62B
$875K 0.02%
+47,051
New +$785K
SKIL icon
193
Skillsoft
SKIL
$72.1M
$802K 0.02%
41,692
– –
EW icon
194
Edwards Lifesciences
EW
$51.5B
$791K 0.02%
10,920
+1,160
+12% +$83K
UWMC icon
195
UWM Holdings
UWMC
$407M
$781K 0.02%
143,000
– –
NVNO
196
enVVeno Medical
NVNO
$6.78M
$779K 0.02%
8,458
– –
AKRO
197
DELISTED
Akero Therapeutics
AKRO
$761K 0.02%
+18,800
New +$797K
ALC icon
198
Alcon
ALC
$33.9B
$759K 0.02%
8,000
-6,039
-43% -$542K
MGM icon
199
PUT
MGM Resorts International
MGM
$11.2B
$752K 0.02%
82,600
-42,400
-34% -$1.42M
SNDX icon
200
Syndax Pharmaceuticals
SNDX
$1.76B
$730K 0.02%
59,438
-30,794
-34% -$434K
6 7
8
9 10

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.